GB Soft key facts
as of Oct 2026- Developer of AI-based non-contact biosignal measurement solutions designed to facilitate remote health monitoring and improve safety across industrial, mobility, and medical sectors.
- GB Soft is valued at approximately $39.9M as of Oct 2026 (last reported valuation).
- It has raised $8.6M; the latest was Later Stage VC ($5.5M) in Jan 2025.
- Notable investors include Tech Incubator Program for Startup, Y&Archer, Comes Investment, HB Investment, IPS Ventures — 7 tracked in total.
- Status: Privately Held (backing).
GB Soft's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·Watch GB Soft: the Monday email on marks, rounds and moves
GB Soft funding rounds
No funding rounds for GB Soft are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
GB Soft valuation
GB Soft's last reported valuation was $39.9 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
GB Soft investors
7 investors are on record for GB Soft, including Tech Incubator Program for Startup, Y&Archer, Comes Investment and HB Investment.
About GB Soft
Developer of AI-based non-contact biosignal measurement solutions designed to facilitate remote health monitoring and improve safety across industrial, mobility, and medical sectors. The company utilizes rPPG (remote photoplethysmography) technology and computer vision to instantly measure pulse, oxygen saturation, blood pressure, and stress levels through standard device cameras, enabling healthcare providers, vehicle manufacturers, and industrial operators to seamlessly monitor vital signs without wearable sensors, optimize patient care, and ensure continuous personal safety.
- Sector
- Healthcare
- HQ
- Daegu, South Korea
- Founded
- 2017
- Employees
- 38
- Website
- gb-soft.co.kr/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.